The greater sophistication and diversity of investors’ asset management needs requires management firms to offer, in a timely manner, products that meet the needs of a wide range of investors. SBI Asset Management leverages its position as an independent management company, and utilizes domestic and overseas resources, to offer not just conventional financial products, such as domestic and overseas stocks and bonds, but alternative investment products as well, including unlisted stocks and hedge funds.
They have selected only quality hedge funds from more than 8,000 that exist worldwide to offer attractive investment opportunities that meet investor needs. They continue to offer domestic and overseas hedge fund investment through domestic investment trust. They also work to ensure timely and easy-to-understand disclosure as they understand that a major pitfall preventing investment in hedge funds is their closed nature and complexity.
SBI Asset Management provides a variety of value-added and professional services for investors, including investment management, investment advice management, foreign investment trust management for overseas subsidiaries, and securities investment corporation management. Through innovative thinking and hard work, SBI Asset Management continuously strive to be the best management firm for every investor they serve.
| Company | Date | Round | Size | Participants |
| Quark Pharmaceuticals | 7/08 | Series E | $27M | 2 |
